{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T21:42:00Z","timestamp":1655502120098},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00108-016-0039-5","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T15:52:21Z","timestamp":1460649141000},"page":"502-507","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Individualisierte Diabetestherapie bei\u00a0\u00e4lteren\u00a0Menschen"],"prefix":"10.1007","volume":"57","author":[{"given":"A.","family":"Zeyfang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"39_CR1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2337\/dc14-0006","volume":"38","author":"RHA Becker","year":"2015","unstructured":"Becker RHA, Dahmen R, Bergmann K et al (2015) New insulin glargine 300 Units. mL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 Units. mL-1. Diabetes Care 38:637\u2013643","journal-title":"Diabetes Care"},{"key":"39_CR2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","volume":"294","author":"CM Boyd","year":"2005","unstructured":"Boyd CM, Darer J, Boult C et al (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294:716\u2013724","journal-title":"JAMA"},{"key":"39_CR3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2337\/dc09-0114","volume":"32","author":"JP Bremer","year":"2009","unstructured":"Bremer JP, Jauch-Chara K, Hallschmid M et al (2009) Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care 32:1513\u20131517","journal-title":"Diabetes Care"},{"key":"39_CR4","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00125-009-1437-1","volume":"52","author":"DG Bruce","year":"2009","unstructured":"Bruce DG, Davis WA, Casey GP et al (2009) Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 52:1808\u20131815","journal-title":"Diabetologia"},{"key":"39_CR5","first-page":"623","volume":"101","author":"L Coll-Planas","year":"2007","unstructured":"Coll-Planas L, Bergmann A, Schwarz P et al (2007) Vergleich der Versorgungsqualit\u00e4t \u00e4lterer Diabetiker durch ambulante Pflegedienste im h\u00e4uslichen Bereich mit der im station\u00e4ren Bereich in Pflegeheimen in Dresden. Z Arztl Fortbild Qualitatssich 101:623\u2013629","journal-title":"Z Arztl Fortbild Qualitatssich"},{"key":"39_CR6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1185\/03007995.2013.821056","volume":"29","author":"SM Curkendall","year":"2013","unstructured":"Curkendall SM, Thomas N, Bell KF et al (2013) Predictors of medication adherence in patients with type 2 diabetes mellitus. Curr Med Res Opin 29:1275\u20131286","journal-title":"Curr Med Res Opin"},{"key":"39_CR7","unstructured":"BARMER GEK (2006) Gesundheitsbericht"},{"key":"39_CR8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00103-012-1662-5","volume":"56","author":"C Heidemann","year":"2013","unstructured":"Heidemann C, Du Y, Schubert I et al (2013) Prevalence and temporal trend of known diabetes mellitus: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:668\u2013677","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ana.24439","volume":"78","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Fink A, Doblhammer G (2015) Effect of pioglitazone medication on the incidence of dementia. Ann Neurol 78:284\u2013294","journal-title":"Ann Neurol"},{"key":"39_CR10","first-page":"543","volume":"107","author":"S Holt","year":"2010","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA (2010) Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 107:543\u2013551","journal-title":"Dtsch Arztebl Int"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","volume":"38","author":"SE Inzucchi","year":"2015","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38:140\u2013149","journal-title":"Diabetes Care"},{"key":"39_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40266-013-0146-0","volume":"31","author":"AM Kuhn-Thiel","year":"2014","unstructured":"Kuhn-Thiel AM, Weiss C, Wehling M (2014) Consensus validation of the FORTA (Fit fOR The Aged) List: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging 31:131\u2013140","journal-title":"Drugs Aging"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.diabres.2014.09.047","volume":"107","author":"UM Mogensen","year":"2015","unstructured":"Mogensen UM, Andersson C, Fosbol EL et al (2015) Metformin in combination with various insulin secretagogues in type 2 diabetes and associated risk of cardiovascular morbidity and mortality - a retrospective nationwide study. Diabetes Res Clin Pract 107:104\u2013112","journal-title":"Diabetes Res Clin Pract"},{"key":"39_CR14","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1210\/jc.2009-1120","volume":"94","author":"RG Naik","year":"2009","unstructured":"Naik RG, Brooks-Worrell BM, Palmer JP (2009) Latent autoimmune diabetes in adults. J Clin Endocrinol Metab 94:4635\u20134644","journal-title":"J Clin Endocrinol Metab"},{"key":"39_CR15","volume-title":"Pharmakotherapie im Alter. Ein Lehrbuch f\u00fcr Praxis und Klinik","year":"1999","unstructured":"Platt D, Mutschler E (Hrsg) (1999) Pharmakotherapie im Alter. Ein Lehrbuch f\u00fcr Praxis und Klinik. Wissenschaftliche Verlagsgesellschaft, Stuttgart"},{"key":"39_CR16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5414\/CP201572","volume":"50","author":"R Quinzler","year":"2012","unstructured":"Quinzler R, Ude M, Franzmann A et al (2012) Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin. Int J Clin Pharmacol Ther 50:24\u201332","journal-title":"Int J Clin Pharmacol Ther"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2337\/dc08-0167","volume":"31","author":"AD Rao","year":"2008","unstructured":"Rao AD, Kuhadiya N, Reynolds K et al (2008) Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality? A meta-analysis of observational studies. Diabetes Care 31:1672\u20131678","journal-title":"Diabetes Care"},{"key":"39_CR18","volume-title":"Insulintherapie - Moderne Konzepte f\u00fcr die Praxis","author":"KP Ratzmann","year":"2010","unstructured":"Ratzmann KP (2010) Insulintherapie - Moderne Konzepte f\u00fcr die Praxis. UNI-MED-Verlag, Bremen \u2013 London \u2013 Boston"},{"key":"39_CR19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/dc14-1142","volume":"38","author":"J Rosenstock","year":"2015","unstructured":"Rosenstock J, Hansen L, Zee P et al (2015) Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin. Diabetes Care 38:376\u2013383","journal-title":"Diabetes Care"},{"key":"39_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0168-8227(00)00195-9","volume":"50","author":"AJ Sinclair","year":"2000","unstructured":"Sinclair AJ, Girling AJ, Bayer AJ (2000) Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 50:203\u2013212","journal-title":"Diabetes Res Clin Pract"},{"key":"39_CR21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jamda.2012.04.012","volume":"13","author":"AJ Sinclair","year":"2012","unstructured":"Sinclair AJ, Morley JE, Rodriguez-Ma\u00f1as L et al (2012) Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 13:497\u2013502","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"39_CR22","first-page":"57","volume":"66","author":"M Wehling","year":"2016","unstructured":"Wehling M (2016) How to use the FORTA (\u201eFit fOR The Aged\u201c) list to improve pharmacotherapy in the elderly. Drug Res 66(2):57\u201362","journal-title":"Drug Res"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/dc15-0658","volume":"38","author":"T Xu","year":"2015","unstructured":"Xu T, Brandmaier S, Messias AC et al (2015) Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care 38:1858\u20131867","journal-title":"Diabetes Care"},{"key":"39_CR24","unstructured":"Zeyfang A et al AAA Geriatrie. http:\/\/www.bethesda-stuttgart.de\/Klinik-fuer-Innere-M.867.0.html . Zugegriffen: 20.3.2016"},{"key":"39_CR25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-0035-1553883","volume":"10","author":"A Zeyfang","year":"2015","unstructured":"Zeyfang A, Bahrmann A, Wernecke J (2015) Praxisempfehlungen Diabetes mellitus im Alter. Diabetol Stoffwechs 10:192\u2013198","journal-title":"Diabetol Stoffwechs"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40801-015-0014-9","volume":"2","author":"A Zeyfang","year":"2015","unstructured":"Zeyfang A, Patzelt-Bath A (2015) Importance of geriatric syndromes in elderly diabetic patients with de novo insulin treatment\u2013 the VEGAS study. Drugs Real World Outcomes 2:73\u201379","journal-title":"Drugs Real World Outcomes"},{"key":"39_CR27","first-page":"151","volume-title":"Gesundheitsbericht Diabetes 2015","author":"A Zeyfang","year":"2015","unstructured":"Zeyfang A (2015) Diabetes und Geriatrie \u2013 Update. In: Gesundheitsbericht Diabetes 2015. Deutsche Diabetes-Gesellschaft, Kirchheim-Verlag, Mainz, S 151\u2013153"},{"issue":"81","key":"39_CR28","first-page":"15","volume":"13","author":"A Zeyfang","year":"2012","unstructured":"Zeyfang A, Berndt S, Aurnhammer G et al (2012) A short easy test can detect ability for autonomous insulin injection by the elderly with diabetes mellitus. J Am Med Dir Assoc 13(81):15\u201318","journal-title":"J Am Med Dir Assoc"},{"key":"39_CR29","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117\u20132128","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0039-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-016-0039-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-016-0039-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T21:13:57Z","timestamp":1655500437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-016-0039-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1007\/s00108-016-0039-5","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,14]]}}}